Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0211 per EA under NDC 29300041305. Its NADAC has been published 279 times since Feb 24, 2021.
Strength
5 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300041305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213324On Market Since
7/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 279 times since Feb 24, 2021, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per EA |
|---|---|
| All-time high | $0.0349 (Mar 10, 2021) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0220 |
| 52-week low | $0.0209 |
| Median price | $0.0231 |
| Average price | $0.0242 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 279 |
| Tracking since | Feb 24, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0211 per EA (NDC 29300041305), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 39.5%. It has been tracked across 279 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Feb 24, 2021, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0349 (Mar 10, 2021), with a median of $0.0231 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 29300041305) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification